Physiotherapy and related activities in multiple sclerosis

Area of Science:

• Neurology
• Rehabilitation Medicine
• Clinical Trials

Background:

• Multiple sclerosis (MS) management increasingly incorporates rehabilitation and physiotherapy interventions.
• Approximately 50 randomized controlled trials (RCTs) have investigated various physiotherapy approaches for MS.
• Existing systematic reviews generally report positive outcomes for these interventions.

Observation:

• Challenges in MS RCTs include blinding of assessors, identifying specific therapeutic components, and defining primary outcomes.
• Many studies assess multiple quality of life and functional domains without clear hypotheses or primary endpoints.
• The short duration of many trials limits understanding of long-term benefits.

Findings:

• Therapeutic inputs in MS trials encompass verbal, physical, and referral strategies, each potentially influencing outcomes.
• 'Response-shift' is a psychological mechanism where perceived quality of life may not align with objective functional status.
• Objective functional assessment is crucial, distinct from subjective quality of life measures.

Implications:

• Future MS trials should randomize specific therapy components against placebos or active controls, rather than no treatment.
• Standardized classification of physiotherapy interventions (type and dosage) is needed.
• Improved trial methodologies, including concealed allocation, assessor blinding, and intention-to-treat analysis, are essential for robust evidence in MS physiotherapy.